OBJECTIVE: Among rheumatoid arthritis (RA) patients who have had the disease for 10 years, more than half have focal erosions, and the risk of fracture is doubled. However, there is little information about the potential relationship between focal erosions and bone mineral density (BMD). The aim of this study was to determine whether lower BMD is associated with higher erosion scores among patients with RA. METHODS: We enrolled 163 postmenopausal women with RA, none of whom were taking osteoporosis medications. Patients underwent dual x-ray absorptiometry at the hip and spine and hand radiography, and completed a questionnaire. The hand radiographs were scored using the Sharp method, and the relationship between BMD and erosions was measured using Spearman's correlation coefficients and adjusted linear regression models. RESULTS: Patients had an average disease duration of 13.7 years, and almost all were taking a disease-modifying antirheumatic drug. Sixty-three percent were rheumatoid factor (RF) positive. The median modified Health Assessment Questionnaire score was 0.7, and the average Disease Activity Score in 28 joints was 3.8. The erosion score was significantly correlated with total hip BMD (r=-0.33, P<0.0001), but not with lumbar spine BMD (r=-0.09, P=0.27). Hip BMD was significantly lower in RF-positive patients versus RF-negative patients (P=0.02). In multivariable models that included age, body mass index, and cumulative oral glucocorticoid dose, neither total hip BMD nor lumbar spine BMD was significantly associated with focal erosions. CONCLUSION: Our results suggest that hip BMD is associated with focal erosions among postmenopausal women with RA, but that this association disappears after multivariable adjustment. While BMD and erosions may be correlated with bone manifestations of RA, their relationship is complex and influenced by other disease-related factors.
OBJECTIVE: Among rheumatoid arthritis (RA) patients who have had the disease for 10 years, more than half have focal erosions, and the risk of fracture is doubled. However, there is little information about the potential relationship between focal erosions and bone mineral density (BMD). The aim of this study was to determine whether lower BMD is associated with higher erosion scores among patients with RA. METHODS: We enrolled 163 postmenopausal women with RA, none of whom were taking osteoporosis medications. Patients underwent dual x-ray absorptiometry at the hip and spine and hand radiography, and completed a questionnaire. The hand radiographs were scored using the Sharp method, and the relationship between BMD and erosions was measured using Spearman's correlation coefficients and adjusted linear regression models. RESULTS:Patients had an average disease duration of 13.7 years, and almost all were taking a disease-modifying antirheumatic drug. Sixty-three percent were rheumatoid factor (RF) positive. The median modified Health Assessment Questionnaire score was 0.7, and the average Disease Activity Score in 28 joints was 3.8. The erosion score was significantly correlated with total hip BMD (r=-0.33, P<0.0001), but not with lumbar spine BMD (r=-0.09, P=0.27). Hip BMD was significantly lower in RF-positive patients versus RF-negative patients (P=0.02). In multivariable models that included age, body mass index, and cumulative oral glucocorticoid dose, neither total hip BMD nor lumbar spine BMD was significantly associated with focal erosions. CONCLUSION: Our results suggest that hip BMD is associated with focal erosions among postmenopausal women with RA, but that this association disappears after multivariable adjustment. While BMD and erosions may be correlated with bone manifestations of RA, their relationship is complex and influenced by other disease-related factors.
Authors: Patrick Garnero; Robert Landewé; Maarten Boers; Arco Verhoeven; Sjef Van Der Linden; Stephan Christgau; Désirée Van Der Heijde; Annelies Boonen; Piet Geusens Journal: Arthritis Rheum Date: 2002-11
Authors: J S Smolen; F C Breedveld; M H Schiff; J R Kalden; P Emery; G Eberl; P L van Riel; P Tugwell Journal: Rheumatology (Oxford) Date: 2003-02 Impact factor: 7.580
Authors: Kurt Redlich; Birgit Görtz; Silvia Hayer; Jochen Zwerina; Nicholas Doerr; Paul Kostenuik; Helga Bergmeister; George Kollias; Günter Steiner; Josef S Smolen; Georg Schett Journal: Am J Pathol Date: 2004-02 Impact factor: 4.307
Authors: Jie Zhang; David T Redden; Gerald McGwin; Leigh F Callahan; Edwin A Smith; Graciela S Alarcón; Larry W Moreland; Désirée M van der Heijde; Elizabeth E Brown; Donna K Arnett; Ted R Mikuls; S Louis Bridges Journal: Arthritis Rheum Date: 2010-08
Authors: Nancy A Shadick; Nicole M Gerlanc; Michelle L Frits; Bradley S Stolshek; Brenna L Brady; Christine Iannaccone; David Collier; Jing Cui; Alex Mutebi; Michael E Weinblatt Journal: Clin Rheumatol Date: 2019-07-29 Impact factor: 2.980
Authors: Sonali P Desai; Ellen M Gravallese; Nancy A Shadick; Roberta Glass; Jing Cui; Michelle Frits; Lori B Chibnik; Nancy Maher; Michael E Weinblatt; Daniel H Solomon Journal: Rheumatology (Oxford) Date: 2009-12-21 Impact factor: 7.580
Authors: Gert Hein; Thorsten Eidner; Peter Oelzner; Michael Rose; Alexander Wilke; Gunter Wolf; Sybille Franke Journal: Rheumatol Int Date: 2010-07-27 Impact factor: 2.631
Authors: Sindhu T Mohanty; Lucksy Kottam; Alessandra Gambardella; Martin J Nicklin; Les Coulton; David Hughes; Anthony G Wilson; Peter I Croucher; Ilaria Bellantuono Journal: Arthritis Res Ther Date: 2010-07-22 Impact factor: 5.156